J. Testa

Molecular Biology · 2001–2013

A researcher in the Science corpus: 5 papers; trusts 6 researchers and is trusted by 4 researchers here, as inferred from the citation graph.

Subfields

Whom J. Testa trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

  1. D. Hanahan
  2. K. Inoki
  3. David Carling
  4. P. Pandolfi
  5. A. Bellacosa

Who trusts J. Testa overall

  1. M. Moasser
  2. L. Larue
  3. A. Bellacosa
  4. D. Altomare
  5. A. Edinger
  6. C. Porta
  7. Marty C. Brandon

Papers from J. Testa's perspective

Ordered by how strongly the researchers J. Testa trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR (Proceedings of the National Academy of Sciences of the United States of America)
  2. TSC2 mediates cellular energy response to control cell growth and survival. (Cell)
  3. mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways (Nature Medicine)
  4. An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/− mice (Proceedings of the National Academy of Sciences of the United States of America)
  5. PTEN: One Gene, Many Syndromes (Human Mutation)
  6. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. (Cancer Research)
  7. The landscape of somatic copy-number alteration across human cancers (Nature)
  8. Dysregulation of the TSC-mTOR pathway in human disease (Nature Genetics)
  9. Does the ribosome translate cancer? (Nature Reviews. Cancer)
  10. Activation of AKT kinases in cancer: implications for therapeutic targeting. (Advances in Cancer Research)

Their papers